Page last updated: 2024-11-04

sulfinpyrazone and Acute Kidney Tubular Necrosis

sulfinpyrazone has been researched along with Acute Kidney Tubular Necrosis in 2 studies

Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.

Research Excerpts

ExcerptRelevanceReference
"Treatment of sulfinpyrazone-induced acute tubular necrosis consists of intravascular hydration, supportive care, and withholding sulfinpyrazone."1.30Acute renal failure due to sulfinpyrazone. ( Goral, S; Stone, W; Walls, M, 1998)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Durham, DS1
Ibels, LS1
Walls, M1
Goral, S1
Stone, W1

Other Studies

2 other studies available for sulfinpyrazone and Acute Kidney Tubular Necrosis

ArticleYear
Sulphinpyrazone-induced acute renal failure.
    British medical journal (Clinical research ed.), 1981, Feb-21, Volume: 282, Issue:6264

    Topics: Acute Kidney Injury; Gout; Humans; Kidney; Kidney Tubular Necrosis, Acute; Male; Middle Aged; Sulfin

1981
Acute renal failure due to sulfinpyrazone.
    The American journal of the medical sciences, 1998, Volume: 315, Issue:5

    Topics: Acute Kidney Injury; Arthritis, Gouty; Humans; Kallikreins; Kidney Tubular Necrosis, Acute; Male; Mi

1998